OptimizeRx Corporation
Index- P/E- EPS (ttm)-0.64 Insider Own3.80% Shs Outstand17.15M Perf Week1.83%
Market Cap221.43M Forward P/E28.38 EPS next Y0.45 Insider Trans0.00% Shs Float14.87M Perf Month-29.25%
Income-11.40M PEG- EPS next Q-0.07 Inst Own83.30% Short Float / Ratio10.00% / 5.86 Perf Quarter-27.07%
Sales62.50M P/S3.54 EPS this Y-22.20% Inst Trans-10.68% Short Interest1.49M Perf Half Y-13.83%
Book/sh7.35 P/B1.74 EPS next Y38.04% ROA-8.20% Target Price21.50 Perf Year-68.54%
Cash/sh4.27 P/C2.99 EPS next 5Y50.00% ROE-8.70% 52W Range12.20 - 43.28 Perf YTD-23.99%
Dividend- P/FCF20.89 EPS past 5Y-24.60% ROI-9.70% 52W High-70.49% Beta1.04
Dividend %- Quick Ratio11.70 Sales past 5Y38.80% Gross Margin62.40% 52W Low4.67% ATR1.05
Employees109 Current Ratio11.70 Sales Q/Q-3.00% Oper. Margin-19.60% RSI (14)30.20 Volatility6.16% 6.51%
OptionableYes Debt/Eq0.00 EPS Q/Q-160.00% Profit Margin-18.30% Rel Volume1.13 Prev Close12.65
ShortableYes LT Debt/Eq0.00 EarningsMar 08 AMC Payout- Avg Volume253.79K Price12.77
Recom1.60 SMA20-20.21% SMA50-25.86% SMA200-33.19% Volume286,422 Change0.95%
Feb-02-23Resumed B. Riley Securities Buy $30
Nov-01-22Initiated Stifel Buy $19
Jul-15-22Initiated SVB Leerink Outperform $38
Oct-18-21Resumed B. Riley Securities Buy $102
Apr-13-21Initiated RBC Capital Mkts Outperform $65
Jan-03-19Initiated William Blair Outperform
Mar-15-23 03:18AM
Mar-14-23 07:30AM
Mar-12-23 08:40AM
Mar-11-23 07:13AM
Mar-10-23 02:39AM
09:06AM Loading…
Mar-09-23 09:06AM
Mar-08-23 05:25PM
Mar-03-23 06:56PM
Mar-02-23 10:54AM
Feb-23-23 08:00AM
Feb-16-23 10:01AM
08:30AM Loading…
Feb-09-23 08:30AM
Jan-21-23 09:12AM
Jan-05-23 06:01AM
Jan-04-23 07:30AM
Nov-28-22 09:31AM
Nov-14-22 10:44AM
Nov-10-22 05:58AM
Nov-08-22 05:35PM
Nov-03-22 06:39AM
Oct-24-22 03:53PM
Oct-20-22 09:00AM
Oct-19-22 04:05PM
Oct-11-22 08:00AM
Sep-23-22 06:23AM
08:00AM Loading…
Sep-20-22 08:00AM
Sep-07-22 08:00AM
Aug-23-22 09:18AM
Aug-19-22 06:19AM
Aug-10-22 09:22AM
Aug-09-22 08:16PM
Aug-02-22 10:00AM
Jul-26-22 07:30AM
Jul-25-22 10:13AM
Jul-21-22 07:30AM
Jul-15-22 03:10PM
Jun-27-22 10:52AM
Jun-23-22 07:30AM
Jun-16-22 12:27PM
Jun-07-22 08:00AM
May-24-22 08:00AM
May-17-22 10:00AM
May-10-22 11:05AM
May-04-22 05:55PM
Apr-29-22 08:00AM
Apr-27-22 03:03PM
Apr-21-22 08:00AM
Apr-20-22 05:33PM
Apr-19-22 09:17AM
Apr-05-22 11:00AM
Mar-29-22 08:00AM
Mar-15-22 08:00AM
Mar-07-22 08:00AM
Feb-25-22 08:01AM
Feb-24-22 05:30PM
Feb-22-22 08:00AM
Feb-17-22 03:03PM
Feb-15-22 08:00AM
Feb-10-22 08:00AM
Feb-07-22 08:00AM
Feb-04-22 01:38PM
Feb-01-22 09:38AM
Jan-31-22 08:00AM
Jan-19-22 07:55AM
Jan-18-22 08:00AM
Jan-03-22 08:00AM
Dec-29-21 08:00AM
Dec-22-21 08:00AM
Dec-15-21 02:38PM
Dec-08-21 08:00AM
Nov-23-21 08:00AM
Nov-22-21 08:00AM
Nov-16-21 08:00AM
Nov-10-21 06:53AM
Nov-09-21 07:25PM
Nov-05-21 08:00AM
Nov-02-21 03:02PM
Oct-30-21 03:00AM
Oct-27-21 08:00AM
Oct-25-21 07:30AM
Oct-21-21 03:22PM
Oct-04-21 01:06PM
Oct-03-21 08:30AM
Oct-02-21 09:00AM
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Odence-Ford MarionGeneral Counsel and CCOMar 01Option Exercise0.0077109,424Mar 03 03:41 PM
Silvestro Stephen LChief Commercial OfficerMar 01Option Exercise0.001,92705,127Mar 03 03:40 PM
Inman ToddChief Technology OfficerMar 01Option Exercise0.007710771Mar 03 03:31 PM
Odence-Ford MarionGeneral Counsel and CCOFeb 11Option Exercise0.004,000010,075Feb 14 11:32 AM
HALAS GUS DDirectorDec 30Option Exercise0.00409065,571Jan 04 04:10 PM
Vos Ellen O'ConnorDirectorDec 30Option Exercise0.00409034,133Jan 04 04:06 PM
WASSON GREGORY DDirectorDec 30Option Exercise0.00409018,674Jan 04 04:07 PM
Lang James PaulDirectorDec 30Option Exercise0.00409039,403Jan 04 04:04 PM
Spangler Patrick DDirectorDec 30Option Exercise0.00409016,826Jan 04 04:04 PM
Odence-Ford MarionGeneral Counsel and CCONov 08Option Exercise0.001,78506,785Nov 10 03:29 PM
Spangler Patrick DDirectorSep 29Option Exercise0.00334016,417Sep 30 04:48 PM
Lang James PaulDirectorSep 29Option Exercise0.00334038,994Sep 30 04:46 PM
HALAS GUS DDirectorSep 29Option Exercise0.00334065,162Sep 30 04:44 PM
WASSON GREGORY DDirectorSep 29Option Exercise0.00334018,265Sep 30 04:39 PM
Vos Ellen O'ConnorDirectorSep 29Option Exercise0.00334033,724Sep 30 04:37 PM
Odence-Ford MarionGeneral Counsel and CCOAug 26Buy15.751,00015,7505,000Aug 30 04:45 PM
FEBBO WILLIAM JCEOAug 22Buy15.2910,700163,642461,772Aug 23 04:45 PM
Lang James PaulDirectorAug 19Buy16.456,00098,72338,660Aug 23 04:45 PM
FEBBO WILLIAM JCEOAug 19Buy16.185,40087,364451,072Aug 23 04:45 PM
Silvestro Stephen LCCOAug 16Buy15.663,20050,1123,200Aug 17 04:46 PM
Vos Ellen O'ConnorDirectorAug 16Buy15.915007,955500Aug 17 04:45 PM
Stelmakh EdwardCFO/COOAug 15Buy15.433,00046,2903,000Aug 17 04:45 PM